carvacrol has been researched along with Parkinson Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashraf, GM; Javed, H; Jha, NK; Mohamed Fizur, NM; Ojha, S | 1 |
| Akan, T; Aydın, Y; Korkmaz, OT; Saydam, F; Ulupınar, E | 1 |
| Bazmandegan, G; Hassanshahi, A; Kamiab, Z; Kujawska, M; Nikbakhtzadeh, M; Ramezanpour, S; Zamanian, MY | 1 |
| Britto, LR; Dati, LM; Feng, ZP; Real, CC; Sun, HS; Ulrich, H | 1 |
| Alaei, H; Haddadi, H; Rajaei, Z; Shahidani, S | 1 |
| Hamzehloei, L; Rajaei, Z; Rezvani, ME | 1 |
2 review(s) available for carvacrol and Parkinson Disease
| Article | Year |
|---|---|
Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases.
Topics: Alzheimer Disease; Antioxidants; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease | 2023 |
Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cymenes; Disease Models, Animal; Humans; Nervous System Diseases; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Phenols; Protein Serine-Threonine Kinases; Stroke; TRPM Cation Channels | 2021 |
4 other study(ies) available for carvacrol and Parkinson Disease
| Article | Year |
|---|---|
The Effects of Carvacrol on Transient Receptor Potential (TRP) Channels in an Animal Model of Parkinson's Disease.
Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Male; Oxidopamine; Parkinson Disease; Rats; Substantia Nigra | 2023 |
Carvacrol promotes neuroprotection in the mouse hemiparkinsonian model.
Topics: Animals; Cymenes; Disease Models, Animal; Male; Mice, Inbred C57BL; Monoterpenes; Neurons; Neuroprotection; Neuroprotective Agents; Parkinson Disease; Substantia Nigra | 2017 |
Chronic treatment with carvacrol improves passive avoidance memory in a rat model of Parkinson's disease.
Topics: Animals; Antioxidants; Antiparkinson Agents; Cymenes; Disease Models, Animal; Lipid Peroxidation; Male; Memory Disorders; Memory, Short-Term; Monoterpenes; Motor Activity; Neuralgia; Oxidopamine; Parkinson Disease; Random Allocation; Rats, Wistar; Reproducibility of Results; Sulfhydryl Compounds; Time Factors; Treatment Outcome | 2018 |
Effects of carvacrol and physical exercise on motor and memory impairments associated with Parkinson's disease.
Topics: Animals; Apomorphine; Cymenes; Disease Models, Animal; Male; Memory Disorders; Motor Activity; Oxidative Stress; Parkinson Disease; Physical Conditioning, Animal; Rats; Rats, Wistar | 2019 |